FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

Electa Instrument Recalls Biopsy Needle Kits

Elekta Instrument AB recalls (Class 1) its Elekta Disposable Biopsy Needle Kit for the Leksell Stereotactic System due to microscopic debris found on ...

latest-news-card-1
FDA General

How Soon Will Trump Nominate Next FDA Head?

FDA watchers need patience as they wait to see who president-elect Donald Trump chooses to nominate as the next FDA commissioner.

latest-news-card-1
Human Drugs

Public Citizen Blasts Potential Drug Approval Change

Public Citizen preemptively criticizes expected 2025 legislation to authorize FDA to approve drugs for rare diseases based on substantial evidence rat...

latest-news-card-1
Federal Register

FDA Ban on Phenylephrine in Nasal Decongestants

Federal Register notice: FDA issues a proposed administrative order to remove orally administered phenylephrine in OTC nasal decongestants.

latest-news-card-1
Medical Devices

Poor Training Found in Lab Inspections

FDA cites a lack of adequate training in FY 2023 Good Laboratory Practice inspection form FDA-483s.

latest-news-card-1
Medical Devices

FDA Approves J&J Varipulse Platform

FDA approves the J&J Varipulse pulsed field ablation platform to treat atrial fibrillation.

latest-news-card-1
Human Drugs

Sarepta Scraps Next-Gen Duchenne Drug

Based on safety concerns, Sarepta says it is discontinuing the development of SRP-5051 (vesleteplirsen) for treating patients with Duchenne muscular d...

latest-news-card-1

IRB Violations Seen in FDA-483s

FDA identifies four trends in IRB violations from FDA-483s issued in FY 2023.

Medical Devices

FDA OKs LumiThera Dry AMD Treatment

FDA grants de novo authorization to LumiTheras Valeda light delivery treatment for dry age-related macular degeneration.

latest-news-card-1
Human Drugs

Caris Companion Diagnostic for Cancer Approved

FDA approves Caris Life Sciences MI Cancer Seek and its use as a companion diagnostic to identify cancer patients for treatment with several targeted ...